| Literature DB >> 31700012 |
Irina Marakhova1, Valentina Yurinskaya2, Nikolay Aksenov2, Valeriy Zenin2, Alla Shatrova2, Alexey Vereninov2.
Abstract
Many evidence shows that K+ ions are required for cell proliferation, however, changes in intracellular K+ concentration during transition of cells from quiescence to cycling are insufficiently studied. Here, we show using flame emission assay that a long-term increase in cell K+ content per g cell protein is a mandatory factor for transition of quiescent human peripheral blood lymphocytes (PBL) to proliferation induced by phytohemagglutinin, phorbol ester with ionomycin, and anti-CD3 antibodies with interleukin-2 (IL-2). The long-term increase in K+ content is associated with IL-2-dependent stage of PBL activation and accompanies the growth of small lymphocytes and their transformation into blasts. Inhibition of PBL proliferation with drugs specific for different steps of G0/G1/S transit prevented both blast-transformation and an increase in K+ content per cell protein. Determination of the water content in cells by measuring the density of cells in the Percoll gradient showed that, unlike the K+ content, the concentration of K+ in cell water remains unchanged, since water and K+ change in parallel. Correlation of proliferation with high cell K+ and water content has been confirmed by the data obtained in comparative study of PBL and permanently cycling Jurkat cells. Our data suggest that K+ is important for successful proliferation as the main intracellular ion that participates in regulation of cell water content during cell transition from quiescence to proliferation. We concluded that high K+ content in cells and the associated high water content is a characteristic feature of proliferating cells.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31700012 PMCID: PMC6838062 DOI: 10.1038/s41598-019-52571-1
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Cell K+ and Na+ contents in human PBL activated to transition from quiescence to proliferation. (a) Changes in cell K+ (Ki) and Na+ (Nai) contents in isolated human PBL stimulated by PHA (10 µg/ml), or PDBu (10 nM) with ionomycin (I, 500 nM) or anti-CD3 (3.5 µg/mL) with IL-2 (100 U/mL). Ki/g (dark symbols) and Nai/g (light symbols) were analyzed at definite time points by flame emission photometry. (b) IL-2 induces a long-term increase in Ki and cell protein content in competent PBL. Isolated PBL were incubated with non-mitogenic PHA (0.8 µg/mL) for 20 hours, then IL-2 (100 U/mL) was introduced into cell culture. Data are means ± SEM of nine (a, PHA and PHA + I), six (a, anti-CD3 with IL-2), or five (b) experiments performed triplicate. Significant difference from the initial value at time 0 (resting PBL) was tested by one-way ANOVA with Tukey’s post hoc tests, *P < 0.01, **P < 0.05. (c) Costimulation with non-mitogenic PHA and IL-2 is accompanied by increased CD25 expression. The representative data of one experiment from five. Control – non-stimulated, resting PBL.
Cell K+, Na+ and water contents, and K+ concentration in human PBL during transit from quiescence to proliferation.
| Incubation | Cation content, µmole/g | Cell water, mL/g protein | [Ki], mM | S + G2 + M, % | ||
|---|---|---|---|---|---|---|
| Ki | Nai | |||||
| 1 | Resting PBL | 613 ± 12 | 110 ± 13 | 4.83 ± 0,15 | 126 | 0,7 ± 0.01 |
| 2 | PHA, 5 h | 500 ± 24 | 215 ± 23 | ND | ND | ND |
| 3 | PHA, 24 h | 742 ± 21 | 140 ± 12 | 6.31 ± 0,37 | 118 | 1.9 ± 0.2 |
| 4 | PHA 48 h | 820 ± 47 | 173 ± 21 | 7.49 ± 0.41 | 110 | 38.9 ± 4.5 |
| 5 | PDBu + I | 760 ± 30 | 193 ± 25 | ND | ND | 41.5 ± 5.8 |
| Anti-CD3 + IL-2, 24 h | 700 ± 50 | 133 ± 48 | 6.1 ± 0.25 | 115 | 1.3 ± 0.02 | |
| 6 | Anti-CD3 + IL-2, 48 h | 785 ± 51 | 148 ± 16 | 7.03 ± 0.6 | 114 | 40.8 ± 3,1 |
| 7 | Competent PBL (0.8PHA, 24 h) | 648 ± 37 | 103 ± 16 | ND | ND | 1.3 ± 0.02 |
| 8 | Competent PBL + IL-2, 48 h | 790 ± 31 | 135 ± 17 | ND | ND | 31.0 ± 5.4 |
| 9 | PHA + CsA, 48 h | 548 ± 41 | 184 ± 8 | ND | ND | 18.1 ± 2.1 |
| 10 | PHA + WHI-P131, 48 h | 516 ± 29 | 177 ± 19 | ND | ND | 11.0 ± 3.9 |
| 11 | Competent PBL + (IL-2 + WHI-P131) 24 h | 599 ± 42 | 169 ± 20 | ND | ND | 5.4 ± 1.7 |
| 12 | Jurkat T cells | 804 ± 101 | 141 ± 32 | 5,84 ± 0.35 | 138 | 37,4 ± 3,2 |
From: Intracellular K+ and water content in human blood lymphocytes during transition from quiescence to proliferation.
Isolated PBL were incubated with 10 μg/ml PHA, or with phorbol ester (PDBu,10 nM) and ionomycin (I, 500 nM), or with anti-CD3 antibodies (3.5 µg/mL) and IL-2 (200 U/mL) for 24 or 48 h. Data for Ki, Nai, cell protein and DNA cytometry are means ± SEM (p ≤ 0.05) of nine (PHA and PDBu + I), four (PHA with inhibitors), six (anti-CD3 antibodies with IL-2), five (competent PBL with IL-2 or with WHI-P131) experiments with PBL and of five experiments with Jurkat T cells. In each experiment, all the values were determined from 3 cultures of PBLs from one donor. Data for cell water per g protein, vprot, was calculated as vprot = (1 − ρ/ρdry)/[0.72(ρ − 1)], taking the density of cell dry mass as 1,38 g/mL and the ratio of protein to dry mass as 72%. Means ± SEM of three independent experiments on PBL from three donors.
Figure 2Long-term increase in cell K+ content precedes DNA synthesis and accompanies transformation of small T cells into large blasts. (A) The protein content increase in PBL stimulated by PHA (10 µg/ml) for 48 hours. Data are means ± SEM of twelve experiments performed triplicate. *Significant difference from the initial value at time 0 (resting PBL) was tested by one-way ANOVA with Tukey’s post hoc tests, P < 0.05. (B) The time course of CD25 expression on small and large PBL stimulated by PHA. Data are means ± SEM of one representative experiment of three. (C) Flow cytometric analysis of cell cycle phase distribution in PHA-stimulated PBL: the percentage of cells in S and (G2 + M) phases. (D) The time course of CD25 expression in PBL stimulated by PHA for 48 hour. Resting or PHA-stimulated PBL were stained with PE-labeled CD25 Abs and analyzed by flow cytometry. (C) and (D) – representative data of three experiments with PBL from different donors. Control - non-stimulated, resting PBL.
Figure 3Cell K+ content and inhibition of proliferation in PHA-stimulated PBL. (a) Time-course of Ki/g in PBL stimulated with PHA alone or in the presence of drugs specific for initial (CsA) or late (WHI-P131) stages of PBL activation. (b) Anti-proliferative doses of CsA and WHI-P131 inhibit growth of PHA-stimulated PBL. Cells were cultivated with 10 µg/mL PHA without or with 80 µM WHI-P131 or 1.0 µg/mL CsA for 48 and at definite time of points were analyzed for Ki by flame emission photometry and for protein content by Lowery procedure. Data are means ± SEM of one representative experiment performed triplicate. *Significant difference relative to PBL stimulated by PHA without drugs during the same time (t-test, P < 0.05).
Figure 4Buoyant density of resting PBL compared to activated PBL and leukemia T cell Jurkat. (a) Schematic illustration of the cell distribution in discontinuous Percoll gradient. Grey areas indicate the location of T cells Jurkat, resting and PHA-activated PBL isolated for analysis. (b,c) Changes in buoyant density in PBL stimulated by PHA (b) and anti-CD3 (3.5 µg/mL) with IL-2 (100 U/mL) (c) for 24 and 48 hours, each column corresponds to a separate layer. One representative experiment of three. (d,e) Flow cytograms of resting PBL in coordinates CD25/FSC (d) and CD14/FSC (e). The representative cytograms of seven experiments on PBL from different donors. (f) The representative cell volume distributions by Scepter Counter in PBL, resting and stimulated by (anti-CD3 and IL-2) mixture for 24 and 48 hours. Control - non-stimulated, resting PBL.
Figure 5Cell K+ and water content in PBL with different buoyant densities as compared to unfractionated activated PBL and cycling T cells Jurkat. (a) Ki/g in light and heavy cell populations. One representative experiment of four. (b) Changes in Ki/g in total unfractionated cell populations. Data are means ± SEM of one representative experiment performed triplicate. *Significant difference relative to control (C) (t-test, P ˂ 0.05). (c) Water content in light and heavy cell populations stimulated with anti-CD3 with IL-2 for 48 hours and in proliferating T cells Jurkat. The same experiment as in (a). (d) Water content in human PBL stimulated from quiescence to proliferation and in proliferating T cells Jurkat. The same experiments as in (b). Data are means ± SEM of one representative experiment performed triplicate. *Significant difference relative to control (C) (t- test, P < 0.05).